This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.
Unlock Better Outcomes in Cardiometabolic Disease Care Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes…
According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…
Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…
This poster explores the impact of the pharmacy liaison-managed care model at CHRISTUS Health System on HbA1c reduction and medication adherence for patients living with diabetes with baseline A1C>9.
This poster presents an evaluation of a social determinants of health screening and intervention framework within an integrated health system specialty pharmacy care model using a closed-loop referral process.
This poster describes the impact of implementing ambulatory clinical pharmacist (ACP)-led medication management services specializing in diabetes care within an integrated HSSP.